Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skeletal Muscle Dysfunction and Exercise Intolerance in ILD
NCT03800017Recruiting
- Sponsor
- University of British Columbia
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Single-blind trial of oxygen in interstitial lung disease (ILD) (2 arms), sponsored by University of British Columbia. Primary endpoints: Change in standardized dyspnea score during the constant load exercise test (visit 3) up to 30 minutes, Change in standardized dyspnea score during the constant load exercise test (visit 4) up to 30 minutes and 2 more. Started Aug 2024; status: recruiting.
02
Drugs
oxygen
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT03800017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800017.